Opinion

Video

Impact of Exacerbations in Type 2 Inflammatory Respiratory Diseases

Author(s):

Reynold A. Panettieri Jr., MD

Reynold A. Panettieri Jr., MD, elaborates on the risks of lung damage resulting from exacerbations, with a focus on the role of type 2 inflammation in triggering these events.

  1. What are the long-term effects of persistent type 2 inflammation on lung function of patients living with asthma or COPD?
  2. What impact does type 2 inflammation have on exacerbation and hospitalization rates in these diseases? How does type 2 inflammation affect disease progression?
Related Videos
Susan Perlman, MD, an expert on Friedreich's ataxia
Ana Baramidze, MD, PhD
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Ticiana Leal, MD, Emory Winship Cancer Institute
Javed Butler, MD
This series features 1 kol.
Anna Mueller, MD, Amir Ahmadi, MD
Related Content
3D illustration of ovarian cancer cells | Image Credit: LASZLO - stock.adobe.com
September 11th 2024

Study: Bevacizumab Significantly Improves Progression-Free Survival in Patients With Epithelial Ovarian Cancer

Brooke McCormick
Adding bevacizumab to the combination therapy of carboplatin and paclitaxel significantly improved progression-free survival (PFS) in patients with epithelial ovarian cancer (EOC) but not overall survival (OS).
Managed Care Cast logo
July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Conversation drawing | Image Credit: Julien Eichinger - stock.adobe.com
September 11th 2024

Social Frailty Indirectly Affects Anxiety, Depression in Patients With AECOPD Through Social Support

Brooke McCormick
Social frailty in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) does not directly impact anxiety or depression but influences these conditions indirectly through social support.
Managed Care Cast
May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

Giuliana Grossi
In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Man getting STI test | Image credit: New Africa - stock.adobe.com
September 10th 2024

Bacterial STIs in Men Living With HIV Associated With Drug Use in Sexual Context

Julia Bonavitacola
Drug use, participation in exchange sex, and depressive symptoms were all found to be associated with bacterial sexually transmitted infections (STIs) in sexual minority men living with HIV.
3D rendering of COVID-19 | Image Credit: Production Perig - stock.adobe.com
September 9th 2024

US COVID-19 Survival Rates Were Affected by Caseload Strain Across Hospitals

Brooke McCormick
During the Delta wave of COVID-19, higher caseload strain negatively impacted patient survival rates across US hospitals, regardless of their size or resources.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo